Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Dublin, March 03, 2017 -- Research and Markets has announced the addition of the "Global Liquid Biopsy Market Analysis 2016 - Forecast to 2022" report to their offering.
Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.
The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.
Scope of the Report
Disease Indication
- Breast Cancer
- Gastrointestinal Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Leukemia
Biomarker
- Exosomes
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor Cells (CTC)
- Single Gene Analysis (PCR Microarrays)
- Multi - gene - parallel Analysis (NGS)
Sample Type
- Urine Sample based
- Blood Sample based
- Saliva
- Tissue fluids
Application
- Molecular Health Monitoring
- Therapy Selection for Metastatic Breast Cancer (MBS)
- Therapy Selection for Other Metastatic Cancer
Company Profiles
- Internap Corporation
- CDN Networks
- Tata Communications
- Level 3 Communications
- Google Inc.
- Limelight Networks, Inc.
- Highwinds Network Group, Inc.
- Akamai Technologies, Inc.
- Verizon Communications, Inc.
- Amazon Web Services, Inc.
- CloudFlare, Inc.
- Orange S.A.
- MaxCDN Enterprise
- Ericssion
- AT&T Inc.
For more information about this report visit http://www.researchandmarkets.com/research/wtw4hh/global_liquid
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics
